{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:32Z","timestamp":1790787512343,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021079","name":"Radcliffe Department of Medicine, University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021079","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["T32-AI07647"],"award-info":[{"award-number":["T32-AI07647"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"Oxford University","doi-asserted-by":"publisher","award":["MRF\/TT2015\/2150"],"award-info":[{"award-number":["MRF\/TT2015\/2150"]}],"id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014816","name":"Graduate Women in Science","doi-asserted-by":"publisher","award":["GR000550"],"award-info":[{"award-number":["GR000550"]}],"id":[{"id":"10.13039\/100014816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.omtm.2019.12.003","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:02:32Z","timestamp":1577145752000},"page":"108-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Targeting Antigen to the Surface of EVs Improves the In\u00a0Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice"],"prefix":"10.1016","volume":"16","author":[{"given":"Carly M.","family":"Bliss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Nachbagauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cappuccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ulaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aled","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-9629","authenticated-orcid":false,"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.12.003_bib1","doi-asserted-by":"crossref","first-page":"16756","DOI":"10.1038\/srep16756","article-title":"Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice","volume":"5","author":"Dicks","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2019.12.003_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.virol.2004.03.047","article-title":"Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses","volume":"324","author":"Roy","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2019.12.003_bib3","doi-asserted-by":"crossref","first-page":"e1000503","DOI":"10.1371\/journal.ppat.1000503","article-title":"Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates","volume":"5","author":"Roy","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2019.12.003_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.meegid.2011.04.031","article-title":"Molecular evolution of human species D adenoviruses","volume":"11","author":"Robinson","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.omtm.2019.12.003_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jphp.12350","article-title":"Adenoviral vectors as novel vaccines for influenza","volume":"67","author":"Coughlan","year":"2015","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.omtm.2019.12.003_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtm.2019.12.003_bib8","doi-asserted-by":"crossref","first-page":"300ra126","DOI":"10.1126\/scitranslmed.aac5745","article-title":"Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults","volume":"7","author":"Green","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of\u00a0an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtm.2019.12.003_bib10","doi-asserted-by":"crossref","first-page":"e0205139","DOI":"10.1371\/journal.pone.0205139","article-title":"First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1","volume":"13","author":"Stephenson","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.12.003_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ymthe.2016.11.003","article-title":"Viral vector malaria vaccines induce high-level t\u00a0cell and antibody responses in West African children and infants","volume":"25","author":"Bliss","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/mt.2016.83","article-title":"Safety and immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants","volume":"24","author":"Afolabi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3389\/fimmu.2017.01551","article-title":"Safety and immunogenicity of malaria vectored vaccines given with routine expanded program on immunization vaccines in Gambian infants and neonates: a randomized controlled trial","volume":"8","author":"Mensah","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib14","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.vaccine.2015.02.004","article-title":"The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T\u00a0cell counts >350 cells\/mm3","volume":"33","author":"Churchyard","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2019.12.003_bib15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2010.519332","article-title":"Production of adenovirus vectors and their use as a delivery system for influenza vaccines","volume":"10","author":"Vemula","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib16","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib17","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.vaccine.2017.04.026","article-title":"Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in\u00a0vivo","volume":"35","author":"Afkhami","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2019.12.003_bib18","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1128\/JVI.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8+ T-cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib20","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in\u00a0vivo and maintain activated CD8+ T\u00a0cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.12.003_bib21","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T\u00a0cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.12.003_bib23","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib24","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.12.003_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1099\/jgv.0.000978","article-title":"Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56","volume":"99","author":"Duffy","year":"2018","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/14760584.2019.1588113","article-title":"A review of 65 years of human adenovirus seroprevalence","volume":"18","author":"Mennechet","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtm.2019.12.003_bib28","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.omtm.2018.07.007","article-title":"A bovine adenoviral vector-based H5N1 influenza -vaccine provides enhanced immunogenicity and protection at a significantly low dose","volume":"10","author":"Sayedahmed","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.12.003_bib30","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of\u00a0the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T\u00a0cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","article-title":"The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species","volume":"33","author":"Dicks","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2019.12.003_bib32","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.12.003_bib33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ni.2647","article-title":"Exosomes mediate the cell-to-cell transmission of IFN-\u03b1-induced antiviral activity","volume":"14","author":"Li","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/ni854","article-title":"Indirect activation of na\u00efve CD4+ T\u00a0cells by dendritic cell-derived exosomes","volume":"3","author":"Th\u00e9ry","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bcmd.2005.07.003","article-title":"Exosome display technology: applications to the development of new diagnostics and therapeutics","volume":"35","author":"Delcayre","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.omtm.2019.12.003_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1083\/jcb.147.3.599","article-title":"Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein Hsc73","volume":"147","author":"Th\u00e9ry","year":"1999","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.12.003_bib39","doi-asserted-by":"crossref","first-page":"24646","DOI":"10.3402\/jev.v3.24646","article-title":"Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms","volume":"3","author":"Sedlik","year":"2014","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtm.2019.12.003_bib40","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1158\/0008-5472.CAN-10-4076","article-title":"Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy","volume":"71","author":"Rountree","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2019.12.003_bib41","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1016\/j.vaccine.2011.09.133","article-title":"Increasing vaccine potency through exosome antigen targeting","volume":"29","author":"Hartman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2019.12.003_bib42","doi-asserted-by":"crossref","first-page":"27269","DOI":"10.3402\/jev.v4.27269","article-title":"Ready-made chromatography columns for extracellular vesicle isolation from plasma","volume":"4","author":"Welton","year":"2015","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtm.2019.12.003_bib43","doi-asserted-by":"crossref","first-page":"E968","DOI":"10.1073\/pnas.1521230113","article-title":"Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes","volume":"113","author":"Kowal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.12.003_bib44","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles","volume":"3","author":"L\u00f6tvall","year":"2014","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtm.2019.12.003_bib45","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtm.2019.12.003_bib46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib47","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2010-03-272336","article-title":"CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells","volume":"117","author":"Bassett","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.12.003_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.176.1.200","article-title":"The CD8+ T\u00a0cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity","volume":"176","author":"Yang","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib49","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2019.12.003_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in\u00a0vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2019.12.003_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2019.12.003_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus","volume":"8","author":"He","year":"2017","journal-title":"Nat. Commun"},{"key":"10.1016\/j.omtm.2019.12.003_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming barriers in the path to a universal influenza virus vaccine","volume":"24","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtm.2019.12.003_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omtm.2019.12.003_bib55","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin G subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.12.003_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.mt.6300024","article-title":"Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector","volume":"15","author":"Hensley","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib57","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","article-title":"Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product","volume":"76","author":"Xiang","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/314952","article-title":"Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection","volume":"180","author":"Moran","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtm.2019.12.003_bib59","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1128\/jvi.70.8.5230-5235.1996","article-title":"Interleukin-4 causes delayed virus clearance in influenza virus-infected mice","volume":"70","author":"Moran","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib60","doi-asserted-by":"crossref","first-page":"eaau2710","DOI":"10.1126\/sciimmunol.aau2710","article-title":"Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine","volume":"4","author":"Matsuda","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib61","doi-asserted-by":"crossref","first-page":"e008748","DOI":"10.1136\/bmjopen-2015-008748","volume":"5","author":"Green","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.omtm.2019.12.003_bib62","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41598-018-21630-4","article-title":"Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP","volume":"8","author":"Bliss","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2019.12.003_bib63","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors","volume":"81","author":"McCoy","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib64","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","article-title":"CD8+ T\u00a0cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib65","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jir850","article-title":"Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector","volume":"205","author":"O\u2019Hara","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtm.2019.12.003_bib66","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"Casimiro","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib67","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-019-08599-y","article-title":"Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions","volume":"10","author":"Baker","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2019.12.003_bib68","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1128\/JVI.77.6.3712-3723.2003","article-title":"The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses","volume":"77","author":"Shayakhmetov","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib69","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/JVI.79.2.1053-1061.2005","article-title":"Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib70","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1128\/JVI.00593-09","article-title":"Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus","volume":"83","author":"Finn","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib71","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.12.003_bib72","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/JVI.74.6.2804-2813.2000","article-title":"Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein","volume":"74","author":"Kirby","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib73","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2019.12.003_bib74","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","article-title":"Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors","volume":"116","author":"Alba","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.12.003_bib75","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/JVI.01878-08","article-title":"Effect of neutralizing sera on factor X-mediated adenovirus serotype 5 gene transfer","volume":"83","author":"Parker","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib76","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.12.003_bib77","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/mt.2008.132","article-title":"Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver","volume":"16","author":"Vigant","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.003_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.12.003_bib79","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1080\/14760584.2017.1394842","article-title":"Chimpanzee adenoviral vectors as vaccines\u2014challenges to move the technology into the fast lane","volume":"16","author":"Vitelli","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtm.2019.12.003_bib80","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.vaccine.2013.02.060","article-title":"An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine","volume":"31","author":"Alejo","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2019.12.003_bib81","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/s41598-018-33375-1","article-title":"Development of a molecular adjuvant to enhance antigen-specific CD8+ T\u00a0cell responses","volume":"8","author":"Halbroth","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2019.12.003_bib82","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1","volume":"3","author":"Lambe","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2019.12.003_bib83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","article-title":"Immunosenescence: emerging challenges for an ageing population","volume":"120","author":"Aw","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.omtm.2019.12.003_bib84","first-page":"413","article-title":"Immunosenescence and influenza vaccine efficacy","volume":"333","author":"Sambhara","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.omtm.2019.12.003_bib85","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.3390\/vaccines6020029","article-title":"Clinical advances in viral-vectored influenza vaccines","volume":"6","author":"Sebastian","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtm.2019.12.003_bib86","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/0008-5472.CAN-07-3163","article-title":"Targeting tumor antigens to secreted membrane vesicles in\u00a0vivo induces efficient antitumor immune responses","volume":"68","author":"Zeelenberg","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2019.12.003_bib87","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/bit.24342","article-title":"Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors","volume":"109","author":"Cottingham","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtm.2019.12.003_bib88","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2019.12.003_bib89","article-title":"Transfection of HEK293-EBNA1 cells in suspension with linear PEI for production of recombinant proteins","author":"Tom","year":"2008","journal-title":"CSH Protoc. 2008"},{"key":"10.1016\/j.omtm.2019.12.003_bib90","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc","volume":"Chapter 3","author":"Thery","year":"2006","journal-title":"Cell Biol"},{"key":"10.1016\/j.omtm.2019.12.003_bib91","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"Van Deun","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2019.12.003_bib92","first-page":"2","article-title":"How pure are your vesicles?","volume":"2","author":"Webber","year":"2013","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtm.2019.12.003_bib93","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtm.2019.12.003_bib94","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1128\/JVI.00445-09","article-title":"In\u00a0vivo retargeting of adenovirus type 5 to \u03b1v\u03b26 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery","volume":"83","author":"Coughlan","year":"2009","journal-title":"J.\u00a0Virol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:13Z","timestamp":1762420993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119301494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":94,"alternative-id":["S2329050119301494"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.003","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Antigen to the Surface of EVs Improves the In\u00a0Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}